Renub Research has released a report titled ” Balloon Catheter Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2030,” which includes market percentage records and a thorough enterprise analysis. This report looks at the Global Balloon Catheter Market’s competition, geographic distribution, and growth potential.
Balloon Catheter Market is predicted to extend at a CAGR of 6.74% from 2024 to 2030
Balloon catheters have come a long way since their invention and have revolutionized medical procedures. Although initially created for angioplasty, they are now used in various scientific fields. Over time, materials advanced, improving flexibility and biocompatibility. Innovations in balloon design facilitated specific dilation of narrowed vessels, decreasing complications. The integration of current technologies improved catheter visibility and navigation during strategies. Also, specialized coatings emerged to address particular medical needs. The evolution of balloon catheters reflects a non-stop quest for improved efficacy, safety, and versatility, positioning them as imperative devices in minimally invasive interventions for various conditions, from cardiovascular to peripheral vascular diseases.
Moreover, the global balloon catheter market has experienced a substantial increase pushed by the rising demand for minimally invasive methods and the prevalence of cardiovascular and peripheral artery illnesses. Technological advancements, including innovative designs and materials, have reinforced the market’s enlargement. The clinical device industry is benefiting from government support, cost-efficient production, and strategic collaborations, contributing to the industry’s growth. As healthcare awareness increases, balloon catheters play an increasingly critical position in diverse medical applications, solidifying their role as quintessential devices in interventional remedies. Hence, Balloon Catheter Market is anticipated to be valued at around US$ 6.99 Billion by 2030.
Besides, the American College of Cardiology reports over 600,000 percutaneous coronary interventions (PCI) in the United States using balloon catheters. The thriving balloon catheter market in North America stems from the multiplied adoption of minimally invasive approaches, pushed by a high incidence of cardiovascular illnesses and non-stop technological improvements. Balloon catheters, transforming minimally invasive techniques, provide less invasive alternatives to open surgical procedures. The future of balloon catheters guarantees customized remedies, advanced protection, and innovative opportunities like smart catheters and AI-powered interventions, heralding a transformative technology in healthcare with the ongoing potential for groundbreaking improvements as research and improvement progress.
The cutting balloon catheter has experienced remarkable growth in the global balloon catheter market, signaling a paradigm shift in vascular intervention
Its progressive design contains microsurgical blades, improving precision in plaque modification throughout angioplasty. This product type has gained traction for its ability to navigate complex lesions, leading to enhanced procedural results. Surgeons increasingly prefer cutting balloon catheters for their efficacy in addressing complex arterial conditions, reducing the risk of complications. As demand rises, manufacturers continue to invest in research and improvement, propelling advancements in this niche section. The substantial expansion of cutting balloon catheters underscores their pivotal function in reshaping interventional cardiology practices globally.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=balloon-catheter-market-p.php
Products Type – Global Balloon Catheter Market Breakup from 6 viewpoints:
- Normal Balloon Catheter
- Drug Eluting Balloon Catheter
- Cutting Balloon Catheter
- Scoring Balloon Catheter
- Stent Graft Balloon Catheter
Peripheral Vascular Disease (PVD) commands a significant share of the global balloon catheter market, reflecting its pivotal role in vascular interventions
As a typical situation affecting arteries outside the coronary heart and brain, PVD necessitates various remedy strategies, where balloon catheters play a critical role. These devices successfully dilate narrowed vessels, restoring blood drift and alleviating symptoms related to PVD. The developing prevalence of peripheral vascular issues propels the need for balloon catheters, prompting continuous innovation in design and technology. This sturdy market presence underscores the vital significance of balloon catheters in addressing the complex challenges posed by peripheral vascular disease on a global scale.
Indication – Worldwide Balloon Catheter Market breakup from 2 viewpoints:
- Coronary Artery Disease
- Peripheral Vascular Disease
Polyurethane holds a substantial share in the global balloon catheter market due to its versatile and advantageous properties
Renowned for its flexibility, sturdiness, and biocompatibility, polyurethane is an idle choice for balloon catheter construction. This versatile polymer enables the manufacturing of balloons with thin yet sturdy partitions, facilitating efficient inflation and deflation for the duration of scientific tactics. Its high-quality tensile energy and resistance enhance the overall performance of balloon catheters, ensuring reliability in various vascular interventions. Moreover, the biostability of polyurethane minimizes the risk of adverse reactions, making it a desired material and solidifying its widespread role in the expanding panorama of the global balloon catheter market.
Raw Materials – Worldwide Balloon Catheter Market breakup from 3 viewpoints:
Clinics flourish in the global balloon catheter market as pivotal hubs for interventional procedures
With a rising emphasis on outpatient care, clinics are at the forefront of minimally invasive remedies, in which balloon catheters play a central role. The shift closer to ambulatory settings aligns with patient options for less invasive techniques, driving the need for catheters that permit specific interventions. Clinics with advanced technology and professional medical experts provide a conducive environment for efficient and cost-effective balloon catheter techniques. This trend displays the broader motion towards outpatient-focused healthcare, elevating clinics as critical players in the ongoing expansion of the global balloon catheter market.
End-User – Balloon Catheter Market Breakup from 4 viewpoints:
- Ambulatory Surgical Centers
- Diagnostic Centers
A focus on the domestic market, coupled with government support and favorable market conditions, has propelled the ascent of China in the balloon catheter market
Rising healthcare awareness propels demand for minimally invasive approaches like balloon catheters, pushed by the surge in chronic illnesses. Government support, subsidies, and tax breaks foster a conducive environment for local balloon catheter manufacturers in China. Chinese firms leverage cost-competitiveness, offering low-cost solutions due to reduced complex work expenses. Ongoing technological improvements, fuelled by significant studies and improvement investments, result in revolutionary balloon catheter designs. Prioritizing the domestic market, Chinese manufacturers focus on meeting specific medical wishes. At the same time, strategic acquisitions and collaborations with foreign entities boost technological capabilities and global market presence, amplifying their growth trajectory.
Country – Balloon Catheter Market Breakup from 26 viewpoints:
- United States
- United Kingdom
- South Korea
- New Zealand
- South Africa
- Saudi Arabia
The global balloon catheter market is dominated by companies such as Abbott Laboratories, Becton Dickinson and Company, Cardinal Health, Teleflex Incorporated, Medtronic Plc., Johnson and Johnson, Edwards Lifesciences Corporation, Stryker Corporation, and Smith & Nephew.
All companies have been covered from 3 viewpoints:
- Recent Developments
- Abbott Laboratories
- Becton Dickinson and Company
- Cardinal Health
- Teleflex Incorporated
- Medtronic Plc.
- Johnson and Johnson
- Edwards Lifesciences Corporation
- Stryker Corporation
- Smith & Nephew
About the Company:
Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076